Treatment of peritoneal metastases from colorectal cancer

被引：34

作者：

Maerz, Loreen ^{[1
]}

Piso, Pompiliu ^{[1
]}

机构：

[1] St John God Hosp Regensburg, Dept Surg, Regensburg, Germany

来源：

GASTROENTEROLOGY REPORT | 2015年 / 3卷 / 04期

关键词：

colorectal cancer; peritoneal metastases; cytoreductive surgery; intraperitoneal chemotherapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; COMPLETE CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; HIGH-RISK; 1ST-LINE TREATMENT; REGIONAL TREATMENT; PLUS HIPEC; CARCINOMATOSIS; TRIAL; ORIGIN;

D O I：

10.1093/gastro/gov044

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Peritoneal seedings of a colorectal tumor represent the second most frequent site of metastasis (after the liver). In the era of 5-fluorouracil (5-FU)-only chemotherapy, the prognosis was poor for colorectal cancer with peritoneal metastases. Within the last few years, new chemotherapeutic and targeted agents have improved the prognosis; however, the response to these treatments seems to be lower than that for liver metastases. The combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy have further improved both disease-free survival and overall survival. Keeping this in mind, every patient presenting with peritoneal metastases from colorectal cancer should be evaluated and receive adequate treatment, if possible in the above-mentioned combination. This paper reviews recent advancements in the therapy of peritoneal carcinomatosis.

引用

页码：298 / 302

页数：5

共 41 条

[11] Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials [J].

Elias, D ;

Delperro, JR ;

Sideris, L ;

Benhamou, E ;

Pocard, M ;

Baton, O ;

Giovannini, M ;

Lasser, P .

ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (05) :518-521

[12] Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin [J].

Elias, Dominique ;

Lefevre, Jeremie H. ;

Chevalier, Julie ;

Brouquet, Antoine ;

Marchal, Frederic ;

Classe, Jean-Marc ;

Ferron, Gwenael ;

Guilloit, Jean-Marc ;

Meeus, Pierre ;

Goere, Diane ;

Bonastre, Julia .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :681-685

[13] Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination [J].

Esquivel, Jesus ;

Elias, Dominique ;

Baratti, Dario ;

Kusamura, Shigeki ;

Deraco, Marcello .

JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) :263-267

[14] Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest [J].

Falcone, Alfredo ;

Ricci, Sergio ;

Brunetti, Isa ;

Pfanner, Elisabetta ;

Allegrini, Giacomo ;

Barbara, Cecilia ;

Crino, Lucio ;

Benedetti, Giovanni ;

Evangelista, Walter ;

Fanchini, Laura ;

Cortesi, Enrico ;

Picone, Vincenzo ;

Vitello, Stefano ;

Chiara, Silvana ;

Granetto, Cristina ;

Porcile, Gianfranco ;

Fioretto, Luisa ;

Orlandini, Cinzia ;

Andreuccetti, Michele ;

Masi, Gianluca .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1670-1676

[15] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].

Ferlay, Jacques ;

Soerjomataram, Isabelle ;

Dikshit, Rajesh ;

Eser, Sultan ;

Mathers, Colin ;

Rebelo, Marise ;

Parkin, Donald Maxwell ;

Forman, David ;

Bray, Freddie .

INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386

[16]

Fiori E, 2004, ANTICANCER RES, V24, P265

[17] Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 [J].

Franko, Jan ;

Shi, Qian ;

Goldman, Charles D. ;

Pockaj, Barbara A. ;

Nelson, Garth D. ;

Goldberg, Richard M. ;

Pitot, Henry C. ;

Grothey, Axel ;

Alberts, Steven R. ;

Sargent, Daniel J. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :263-267

[18] Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study [J].

Glehen, O ;

Kwiatkowski, F ;

Sugarbaker, PH ;

Elias, D ;

Levine, EA ;

De Simone, M ;

Barone, R ;

Yonemura, Y ;

Cavaliere, F ;

Quenet, F ;

Gutman, M ;

Tentes, AAK ;

Lorimier, G ;

Bernard, JL ;

Bereder, JM ;

Porcheron, J ;

Gomez-Portilla, A ;

Shen, P ;

Deraco, M ;

Rat, P ;

Gilly, FN .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3284-3292

[19] A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial [J].

Glockzin, Gabriel ;

Rochon, Justine ;

Arnold, Dirk ;

Lang, Sven A. ;

Klebl, Frank ;

Zeman, Florian ;

Koller, Michael ;

Schlitt, Hans J. ;

Piso, Pompiliu .

BMC CANCER, 2013, 13

[20] Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab [J].

Goere, Diane ;

Gras-Chaput, Nathalie ;

Auperin, Anne ;

Flament, Caroline ;

Mariette, Christophe ;

Glehen, Olivier ;

Zitvogel, Laurence ;

Elias, Dominique .

BMC CANCER, 2014, 14

← 1 2 3 4 5 →